Quarterly report · Q1
7776.TEDINET S100TFKG
Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 32
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥34m | 2024-01-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥190m | 2023-01-01 → 2023-12-31 | Standalone | Net sales (5-year summary) |
| Revenue | ¥31m | 2023-01-01 → 2023-03-31 | Standalone | Net sales |
| Operating income | −¥233m | 2024-01-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥182m | 2023-01-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥231m | 2024-01-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥710m | 2023-01-01 → 2023-12-31 | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Ordinary income |
| Profit before tax | −¥229m | 2024-01-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥230m | 2024-01-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥847m | 2023-01-01 → 2023-12-31 | Standalone | Net income loss (5-year summary) |
| Net income | −¥184m | 2023-01-01 → 2023-03-31 | Standalone | Profit loss |
| Total assets | ¥2.4bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2023-12-31 | Standalone | Assets |
| Total assets | ¥2.0bn | at 2023-03-31 | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥291m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥301m | at 2023-12-31 | Standalone | Liabilities |
| Net assets / equity | ¥2.1bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.2bn | at 2023-12-31 | Standalone | Net assets |
| Net assets / equity | ¥1.6bn | at 2023-03-31 | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-12-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-7.24 | 2024-01-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-29.43 | 2023-01-01 → 2023-12-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.81 | 2023-01-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 86.9% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 86.9% | at 2023-12-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 79.2% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 32,172,719 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 31,459,019 | at 2023-12-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 27,659,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2024-01-01 → 2024-03-31 | −¥55m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥387,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥387,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥164m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2024-01-01 → 2024-03-31 | ¥34m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2024-01-01 → 2024-03-31 | ¥34m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2024-01-01 → 2024-03-31 | −¥13m |
| —segment total | revenue | 2024-01-01 → 2024-03-31 | ¥34m |
| —segment total | revenue external | 2024-01-01 → 2024-03-31 | ¥34m |
| —segment total | segment profit | 2024-01-01 → 2024-03-31 | −¥177m |
| Reconciling Itemsreconciling | segment profit | 2023-01-01 → 2023-03-31 | −¥54m |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥249,000 |
| jpcrp040300-q1r_E24158-000Cell Sheet Regenerative Medicinereportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥115m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | revenue external | 2023-01-01 → 2023-03-31 | ¥30m |
| jpcrp040300-q1r_E24158-000Laboratory Consumable Equipmentreportable segment | segment profit | 2023-01-01 → 2023-03-31 | −¥13m |
| —segment total | revenue | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | revenue external | 2023-01-01 → 2023-03-31 | ¥31m |
| —segment total | segment profit | 2023-01-01 → 2023-03-31 | −¥128m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 298
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report non consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)けやき監査法人 | |
| Cpa1 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)宮 下 圭 二 | |
| Cpa2 audit firm1 non consolidated | FilingDateInstant | Original text (Japanese)吉 村 潤 一 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | 30696000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | 34238000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 190134000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -184365000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -231484000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -710276000 | JPY |
| Net income loss (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -183993000 | JPY |
| Net income loss (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -229665000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -846534000 | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | JPY |
| Equity in earnings losses of affiliates if equity method is applied (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | JPY |
| Capital stock (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 1785784000 | JPY |
| Capital stock (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 2459243000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2384311000 | JPY |
| Total number of issued shares (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 27659419 | |
| Total number of issued shares (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 32172719 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 31459019 | |
| Net assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 1629871000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 2083201000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2164721000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 2029194000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 2373855000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 2465768000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | -6.81 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | -7.24 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -29.43 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | CurrentYTDDuration_NonConsolidatedMember | － | |
| Dividend paid per share (5-year summary) | Prior1YearDuration_NonConsolidatedMember | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant_NonConsolidatedMember | 0.792 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant_NonConsolidatedMember | 0.869 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 0.869 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 32172719 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 32203819 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 32172719 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 32203819 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 100 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 10 of 10 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |